Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1126 - 1150 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ06
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261625 1309.884979 C68H127NO22
Diacylglycerophosphoinositolglycans LMGP15010105
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(17:0/16:0)
126457473 1310.699958 C60H111O28P
Diacylglycerophosphoinositolglycans LMGP15010128
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/14:0)
126457496 1310.699958 C60H111O28P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AB04
  • GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Globoside I/Cytolipin K(d18:1/22:0)
44260175 1310.843843 C66H122N2O23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AS04
  • GlcNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260311 1310.843843 C66H122N2O23
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AB04
  • Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • asialo-GM1(d18:1/22:0)
44260495 1310.843843 C66H122N2O23
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AB04
  • Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • iso-LM1(d18:1/22:0)
44260623 1310.843843 C66H122N2O23
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AA04
  • Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • nLc4Cer(d18:1/22:0)
70699268 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AP04
  • Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261935 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR04
  • Cytolipin R(d18:1/22:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261575 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT04
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261591 1310.843843 C66H122N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF04
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261671 1310.843843 C66H122N2O23
Gangliosides LMSP0601DC01
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262572 1314.765988 C63H114N2O26
Gangliosides LMSP0601DG01
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • KDN-GM2(d18:1/16:0)
44262604 1314.765988 C63H114N2O26
Diacylglycerophosphoinositolglycans LMGP15010125
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:2(9Z,12Z))
126457493 1316.653008 C61H105O28P
Diacylglycerophosphoinositolglycans LMGP15010119
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:2(9Z,12Z))
126457487 1318.668658 C61H107O28P
Diacylglycerophosphoinositolglycans LMGP15010124
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:1(9Z))
126457492 1318.668658 C61H107O28P
Diacylglycerophosphoinositolglycans LMGP15010113
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/16:2(9Z,12Z))
126457481 1320.684308 C61H109O28P
Diacylglycerophosphoinositolglycans LMGP15010118
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:1(9Z))
126457486 1320.684308 C61H109O28P
Diacylglycerophosphoinositolglycans LMGP15010123
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:2(9Z,12Z)/16:0)
126457491 1320.684308 C61H109O28P
LMSL03001283
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-hexatriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/36:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457724 1320.981127 C73H140O17S
LMSL03001294
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R,14R,16R,18R-nonamethyl)-19-hydroxy-tetratriacontanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/34:0(2Me[S],4Me[S],6Me[S],8Me[S],10Me[S],12Me[R],14Me[R],16Me[R],18Me[R],19OH))
126457735 1320.981127 C73H140O17S
Diacylglycerophosphoinositolglycans LMGP15010103
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(16:0/18:1(9Z))
126457471 1322.699958 C61H111O28P
Diacylglycerophosphoinositolglycans LMGP15010112
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:0/16:1(9Z))
126457480 1322.699958 C61H111O28P
Diacylglycerophosphoinositolglycans LMGP15010117
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(18:1(9Z)/16:0)
126457485 1322.699958 C61H111O28P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024